My academic career to date brings together my training in clinical oncology (radiation and medical oncology) with national and global health services research, with a particular focus on evidence-based policy implementation and impact. I have a wide skill set in research methodologies including epidemiology, demography, geographic information systems, econometrics, and qualitative methods. 

I have contributed significantly to national and international policy discussion around the affordability of cancer care and the value of new technologies in cancer medicine, which has directly influenced both WHO Cancer Drug Pricing and Benefits Taskforces, and the European Medicines Agency. I am directly involved in international policymaking within the European Commission and ESTRO (European Society of Radiation Oncology) to inform reimbursement of medical devices. In 2017, I completed a NIHR Doctoral Research Fellowship at LSHTM which identified patient choice and hospital competition as key drivers in the adoption of robotic surgery for cancer treatment in the NHS. 

I have experience and expertise in global health research. I have previously worked at the World Health Organisation in Geneva in the TB disease domain, and have ongoing global health projects aimed at building radiotherapy capacity and research capability in low and middle income countries. I was recently awarded, in collaboration with the MD Anderson Cancer Centre, USA, and Stellenbosch University, South Africa, a Wellcome Trust Digital Innovator Award, to use Artificial Intelligence to automate radiotherapy treatment planning for the treatment of urgent and emergency presentations of advanced cancers.